Delivery Order SPE2DB22D1002-SPE2DB25FLEY9

Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,876.95 firm fixed-price delivery order contract is for the supply of Risperdal 2 mg tablets. The contract has an ultimate completion date of January 25, 2024. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,759.83 firm fixed-price delivery order contract is to supply Risperdal 1 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. While the original solicitation was not provided, the award indicates that it was not designated with any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,682.65 firm-fixed-price delivery order is for the supply of Risperdal 1 mg tablets, a pharmaceutical product used for mental health treatment. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,062.01 Firm Fixed Price delivery order contract is for the supply of RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on July 16, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,382.54 firm fixed-price delivery order is for the supply of Risperdal 2 mg tablets, a medication commonly used for the treatment of mental health conditions. The contract, which has an ultimate completion date of September 29, 2022, is not designated as a set-aside. It is a child contract under a larger...
This federal contract award, identified as SPE2DB22D3301|SPE2DB25FX9GE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,241.28, is for the delivery of Risperdal 1 mg tablets in quantities of 60 per bottle. This is a firm fixed-price Delivery Order contract with a completion date of January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award is for the delivery of Risperdal 2 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,091.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 27, 2023, with a completion date of September 28, 2023. The contract is not designated as a set-aside and was awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,260.89 firm-fixed-price delivery order is for the supply of 4,567,240,522 units of 2 mg Risperidone tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award, with an ID of SPE2DB24D1034|SPE2DB25FWAP0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution and healthcare solutions provider. The $6,683.79 firm fixed-price delivery order is for the supply of Risperdal 4 mg tablets and has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,397.16, is for the delivery of Risperdal 2 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FLEY9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,493.20 firm fixed price delivery order is for the supply of Risperdal 0.5 mg tablets, a pharmaceutical product.

The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, designated as SPE2DX. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract award did not utilize any set-aside designations and was competitively awarded, indicating Amerisourcebergen Drug Corp's capability to meet federal procurement requirements through open competition. The contract has an ultimate completion date of July 17, 2025.

Generated 10/15/25, 9:51 AM